Verified peer comparison
Valion Bio vs GP-Act III Acquisition Financial Comparison
Direct answer
Valion Bio and GP-Act III Acquisition are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Valion Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Valion Bio Revenue
- 382,000 USD
- GP-Act III Acquisition Revenue
- 0 USD
- Valion Bio Operating income
- -768,000 USD
- GP-Act III Acquisition Operating income
- -551,918 USD